Press Release

Genital Herpes Treatment Market to Grow at 4.1% CAGR by 2027

July, 2021

" COVID-19 impact on genital herpes treatment market, size, share, growth, industry analysis, and forecast 2021-2027 "

Genital herpes is a disease which is sexually transmitted and is caused by a viral pathogen, herpes simplex virus (HSV). HSV is carried out by infected people’s semen, saliva, and vaginal secretions: HSV-1 and HSV-2 are two variants of herpes simplex viruses. There are various common symptoms of genital herpes, such as blisters on genital organs, blisters in the lips/mouth, vaginal discharge, etc. Antiviral drugs such as Acyclovir, Famciclovir, and Valacyclovir are commercially available therapeutics for the treatment of genital herpes.

Rising awareness about sexually transmitted diseases and an increase in the government expenditure to develop innovative therapeutics for genital herpes treatment augment the market growth during the forecast period. In addition, precise diagnostic tests, including competitive polymerase chain reactions (PCR), DNA enzyme immunoassay hybridization, and real-time PCR assay, are extremely used to diagnose STIs in emerging countries. These tests are vital for the diagnosis of asymptomatic infections, which would spur the demand for genital herpes treatment and compel the market.

Request for sample copy of the report @

The lower awareness about sexually transmitted diseases in developing economies has made them vulnerable. The lack of infrastructure, diagnostic services, and relatively high cost of treatment have been restraining the market growth in these economies. However, the new technological developments are expected to lower the cost barrier, enabling routes for increasing awareness and increased treatment opportunities for the population in low-income economies.

Genital Herpes Treatment Market research report titled “Genital Herpes Treatment Market by Type of Drugs, Distribution channels, Route of Administration and Geography - Forecast up to 2027

Few well-known companies of the genital herpes treatment market are Novopharm Ltd., Teva Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Genocea Biosciences, and Mylan Pharmaceuticals Inc.

Effectual treatment guidelines will propel the genital herpes treatment market growth in North America. Apart from that, the Asia Pacific market is expanding rapidly over the forecast period due to the increasing consciousness about public health and the existence of huge generic drugs to treat genital herpes infection.

Access full report summary @

The report consists of 94 Tables and 64 charts depicting the in-depth market study and the impact analysis of COVID-19. View detailed TOC here.

Genital Herpes Treatment Market on the basis of Type of Drugs

  • Acyclovir
  • Famciclovir
  • Valacyclovir
  • Others

Genital Herpes Treatment Market on the basis of Distribution channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug stores
  • Online Pharmacies

Genital Herpes Treatment Market on the basis of Route of Administration

  • Oral
  • Topical

Genital Herpes Treatment Market on the basis of Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Mr. Karthick Subramani

Infoholic Research LLP

Marketing & Communication